Inspire Advisors’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Inspire Advisors’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-53	Closed	–	–	790
2020 Q4	$0	Buy	+53	New	+$454	﹤0.01%	826

Other funds holding CYAD

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Inspire Advisors's CYAD Position: Q1 2021 in Review

Inspire Advisors sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q1 2021, closing a stake of 53 shares.

Inspire Advisors first reported a position in CYAD in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 6 funds tracked by Wall St. Rank hold CYAD as of Q1 2021.

Inspire Advisors reported no remaining Celyad Oncology SA American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Inspire Advisors sold 53 Celyad Oncology SA American Depositary Shares shares in Q1 2021.
Inspire Advisors first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2020 and held it in 1 quarter.
Inspire Advisors's Celyad Oncology SA American Depositary Shares position peaked at $0 in Q4 2020.
6 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q1 2021.

Based on Inspire Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.